An MTT assay was performed to assess the anti-proliferative effect of the compound on two adenocarcinoma cell lines. Exponentially growing cells were exposed to various concentrations of the compound for 24 h and 48 h. The results showed that the compound inhibited the proliferation of the both the cell lines in a concentration dependent manner (Supplementary Figure S1 A-D). The determined half maximal inhibitory concentration values (IC50) of the compound on the two cell lines is presented in Supplementary Table S1 . Supplementary Figure S1: Cytotoxic effect of the quinazoline derivative (Compound A) on MDA-MB-231 and MDA-MB-415 cell lines. An MTT assay was done to evaluate the cytotoxic effect of the compound on MDA-MB-231 and MDA-MB-415. Cyclophosphamide was used as a standard anti-cancer drug. (A) Effect of compound A and Cyclophosphamide on viability of MDA-MB-231 cells (24 h), (B) Effect of compound A and Cyclophosphamide on viability of MDA-MB-231 cells (48 h), (C) Effect of compound A and Cyclophosphamide on viability of MDA-MB-415 cells (24 h), (D) Effect of compound A and Cyclophosphamide on viability of MDA-MB-415 cells (48 h)
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Data are presented as mean ± SD of three independent experiments.
Apoptotic potential of the compound on MDA-MB-231 and MDA-MB-415 cell lines
The apoptotic potential of the compound on MDA-MB-231 and MDA-MB-415 cell lines was evaluated by flow cytometry. The results indicated that the compound induced apoptosis of the two cell lines in a concentration dependant manner. Significant increase in apoptotic cell percentage was observed in MDA-MB-231 cells treated with 15 µ g/ml of the compound onwards as compared to those of control.
In case of MDA-MB-415 cells, a little more concentration of the compound (25 µ g/ml) was required for significant increase of apoptotic cells as compared to control (Supplementary Figure S2 ). followed by Dunnett post-test was performed to find out significant difference among control and treatments. * denotes p≤0.05; ** denotes p≤0.01; *** denotes p<0.001
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Apoptosis on MCF-10A treated with compound A
The effect of the compound A on apoptosis of the MCF-10A cells was investigated by Flow
Cytometry and no significant difference of apoptotic cell percentage between treated cells and control was found (Supplementary Figure S3 ). This indicates that Compound A was less cytotoxic towards MCF-10A cells. MCF-10A cells cultured in absence of the compound A showed 4.74 % apoptotic cells and 5.33, 6.61 and 7.01 % following the addition of 15, 25 and 50 µ g/ml compound A for 24 h treatment .
Supplementary Figure S3 . Apoptotic potential of the Compound A on MCF-10A cells. The histogram shows the mean Annexin V-positive MCF-10A cells (mean ± SD) of three experiments. One-way analysis of variance (ANOVA) followed by Dunnett post-test was performed to find out significant difference among control and treatments. * denotes p≤0.05; ** denotes p≤0.01.
ROS production on MCF-10A treated with compound A
Effect of Compound A on ROS production in MCF-10A cells was evaluated and no significant differences in ROS production between treated cells and control cell was observed (Supplementary
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